Q/C Technologies, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Q/C Technologies, Inc. (QCLS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.48 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2019-11-14
- Q/C Technologies, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2018-09-30 was $1.48K, a 65.79% decline year-over-year.
- Q/C Technologies, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2018-06-30 was $2.74K, a 46.74% decline year-over-year.
- Q/C Technologies, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2018-03-31 was $2.71K, a 46.15% decline year-over-year.
- Q/C Technologies, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2017-12-31 was $2.77K.
- Q/C Technologies, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was $17.27K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2018-09-30 | $1.48K 10-Q · filed 2019-11-14 | $4.22K derived: sum of 2 quarters · filed 2019-11-14 | $6.93K derived: sum of 3 quarters · filed 2019-11-14 | $9.70K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $2.74K 10-Q · filed 2019-11-14 | $5.45K derived: sum of 2 quarters · filed 2019-11-14 | $8.23K derived: sum of 3 quarters · filed 2019-11-14 | $12.54K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-03-31 | $2.71K 10-Q · filed 2019-11-14 | $5.48K derived: sum of 2 quarters · filed 2019-11-14 | $9.80K derived: sum of 3 quarters · filed 2019-11-14 | $14.95K derived: sum of 4 quarters · filed 2019-11-14 |
| 2017-12-31 | $2.77K derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-04-01 | $7.09K derived: sum of 2 quarters · filed 2019-04-01 | $12.24K derived: sum of 3 quarters · filed 2019-04-01 | $17.27K 10-K · filed 2019-04-01 |
| 2017-09-30 | $4.32K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-07-13 | $9.47K derived: sum of 2 quarters · filed 2018-07-13 | $14.50K 10-Q/A · filed 2018-07-13 | |
| 2017-06-30 | $5.15K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13 | $10.18K 10-Q/A · filed 2018-07-13 | ||
| 2017-03-31 | $5.04K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |